Possibly as they become closer to commercialisation the company has seen there could have been an IP conflict here? Great to see PAA moving forward and having results before years end.
Ann: PharmAust & Nihon Nohyaku Japan Enter Assignment Agreement, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.020(8.89%) |
Mkt cap ! $96.99M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.5¢ | 22.5¢ | $150.8K | 649.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 50607 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
0.020 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 24.0¢ | 22.5¢ | 231366 | ||
| Last updated 15.56pm 17/06/2024 ? | |||||
| PAA (ASX) Chart |
